Login / Signup

Acceptance and commitment therapy for high frequency episodic migraine without aura: Findings from a randomized pilot investigation.

Licia GrazziFrank AndrasikPaul B RizzoliCarolyn A BernsteinEmanuela SansoneAlberto Raggi
Published in: Headache (2021)
Our preliminary findings indicate that supplementing TAU with ACT can enhance the main clinical outcomes, namely headache frequency and medication intake of patients with HFEM.
Keyphrases
  • high frequency
  • transcranial magnetic stimulation
  • cerebrospinal fluid
  • study protocol
  • adverse drug
  • healthcare
  • weight gain
  • randomized controlled trial
  • cell fate
  • clinical trial
  • electronic health record